Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
106M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
3.41M
-
Shares change
-
+678K
-
Total reported value, excl. options
-
$3.61M
-
Value change
-
+$286K
-
Put/Call ratio
-
0.02
-
Number of buys
-
17
-
Number of sells
-
-8
-
Price
-
$1.06
Significant Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) as of Q4 2023
37 filings reported holding SLS - SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.41M shares
of 106M outstanding shares and own 3.22% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.15M shares), ARMISTICE CAPITAL, LLC (820K shares), BlackRock Inc. (280K shares), GEODE CAPITAL MANAGEMENT, LLC (246K shares), GROUP ONE TRADING, L.P. (186K shares), Equitable Holdings, Inc. (165K shares), Opus Capital Group, LLC (135K shares), STATE STREET CORP (97.1K shares), NORTHERN TRUST CORP (62.4K shares), and Virtu Financial LLC (59.9K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.